Our study shows that low expression of CCBL2 is associated with low OS in BC, especially in ER-positive tumors, PR positive tumors, HER-2 negative tumors, luminal A tumors, and invasive ductal and lobular carcinomas. Here, ERBB2 is linked to breast cancer.